资讯
2 小时之前
Scribe Therapeutics Presents New Data Advancing the Potential of Ultra-Long-Acting Genetic Medicines for Cardiovascular Disease at AHA Scientific Sessions 2026
临床结果基因疗法AHA会议
2 小时之前
HUTCHMED Announces China NMPA Approval of SYVIK® (sovleplenib) for the Treatment of Primary Immune Thrombocytopenia and Warm Antibody Autoimmune Hemolytic Anemia
临床结果免疫疗法上市批准孤儿药
2 小时之前
Gastric cancer filing for AstraZeneca's Claudin 18.2-targeting ADC gets speedy FDA review
抗体药物偶联物临床结果优先审批上市批准
2 小时之前
Recursion Announces Alignment with FDA on Registrational Phase 3 Trial Design for REC-4881 in Familial Adenomatous Polyposis
临床结果快速通道孤儿药
2 小时之前
Sanofi secures first FDA approval to treat neurological symptoms in rare metabolic disease
上市批准突破性疗法临床结果
2026-11-20
Immuneering Presents Additional Data Demonstrating Atebimetinib’s Broad Potential as a Backbone for Combination Therapy in Pancreatic Cancer
临床结果AACR会议
2026-11-20
Olema Oncology Presents Preclinical Data on Selective KAT6A Degraders in ER+/HER2- Breast Cancer Models at EORTC-NCI-AACR Symposium
临床结果AACR会议
2026-11-20
Telomir Pharmaceuticals Selects Linical to Advance FDA-Cleared Phase 1/2 Clinical Trial of Telomir-Zn in Triple-Negative Breast Cancer
临床申请临床研究引进/卖出
2026-11-20
Visara Announces First Patient Dosed in ASCEND Phase 2b Trial of VIS-101 in Wet AMD
临床结果
2026-11-20
Providence Therapeutics Enrolls First Patient in World’s First Clinical Trial of a Personalized mRNA Vaccine for Pediatric Brain Cancer
疫苗信使RNA临床研究免疫疗法